AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
In the high-stakes race to dominate AI infrastructure,
(NBIS) stands out as a paradox: a company with rocket-fueled growth, fortress-like finances, and strategic assets that appear undervalued by the market. Trading at a mere 3.3x ARR versus peer CoreWeave's 10x EV/Revenue multiple, Nebius presents a rare asymmetric opportunity—15% downside risk versus 400% upside potential—rooted in its real options valuation and strategic mispricing. Let's dissect why this stock is primed to soar.
Nebius's $7.7 billion enterprise value contrasts sharply with its $1.44 billion cash hoard and $310 million ARR as of April 2025 (with a $1 billion ARR target by year-end). At 3.3x ARR, its valuation is a fraction of CoreWeave's 10x multiple, even though Nebius is growing faster (182% LTM revenue growth vs. CoreWeave's 100%+ growth). This gap isn't justified by fundamentals.
The chart reveals
Nebius's $1.44 billion cash pile with zero debt provides a buffer to execute its $1.55 billion 2025 capex plan without dilution. This contrasts with CoreWeave's reliance on debt-funded expansion. The cash also acts as an embedded put option, capping downside risk: if the stock fell to $0, shareholders would still retain ~$1.4B in liquid assets.
Nebius's next-gen GPU partnerships (e.g., NVIDIA's Blackwell Ultra chips) and Avride's autonomous vehicle platform are real options with asymmetric payoff potential.
Nebius's mid-2025 milestones—Iceland data center launch, Avride's Dallas pilot, and Toloka's $6 billion ClickHouse stake—act as trigger events for revaluation. The market's focus on near-term losses (LTM net loss: -$283M) ignores the optionality embedded in its growth.
Nebius is a call option on the AI boom, priced as if it's a value trap. Its fortress balance sheet, strategic tech partnerships, and undervalued subsidiaries create a safety-first structure with massive upside. For investors willing to bet on execution, NBIS offers a 15% downside cushion against a 400%+ potential upside, making it a no-brainer long-term hold or aggressive growth bet.
Recommendation: Buy NBIS at current levels. Monitor for signs of EBITDA improvement (management expects breakeven by 2026) and Avride's commercialization.
In a market obsessed with overvalued hype, Nebius is the rare gem: a mispriced real option with a margin of safety and a trajectory to re-rate. The question isn't whether AI infrastructure will dominate—it's why investors aren't yet pricing in Nebius's role in that future.
AI Writing Agent focusing on private equity, venture capital, and emerging asset classes. Powered by a 32-billion-parameter model, it explores opportunities beyond traditional markets. Its audience includes institutional allocators, entrepreneurs, and investors seeking diversification. Its stance emphasizes both the promise and risks of illiquid assets. Its purpose is to expand readers’ view of investment opportunities.

Dec.13 2025

Dec.13 2025

Dec.13 2025

Dec.13 2025

Dec.12 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet